--- title: "Bridge Round, Definition | MedTech Terms" description: "Interim financing between priced rounds, usually convertible. Plain-English Investment & Finance definition for MedTech teams, with examples and related terms." lang: en json-ld: | { "@context": "https://schema.org", "@graph": [ { "@type": "DefinedTerm", "@id": "https://medtechterms.com/terms/bridge-round#term", "name": "Bridge Round", "description": "A bridge round is short-term financing - typically a convertible note or SAFE - that extends runway to the next priced round or a defined milestone.", "url": "https://medtechterms.com/terms/bridge-round", "termCode": "bridge-round", "inDefinedTermSet": { "@type": "DefinedTermSet", "name": "MedTech Terms", "url": "https://medtechterms.com/terms" } }, { "@type": "Article", "@id": "https://medtechterms.com/terms/bridge-round#article", "headline": "Bridge Round", "description": "Interim financing between priced rounds, usually convertible.", "url": "https://medtechterms.com/terms/bridge-round", "mainEntityOfPage": { "@type": "WebPage", "@id": "https://medtechterms.com/terms/bridge-round" }, "about": { "@id": "https://medtechterms.com/terms/bridge-round#term" }, "articleSection": "Investment & Finance", "inLanguage": "en", "keywords": "Bridge Round, Investment & Finance, medical device, MedTech", "author": { "@type": "Person", "name": "Christian Espinosa", "jobTitle": "Founder, Blue Goat Cyber", "url": "https://bluegoatcyber.com" }, "publisher": { "@type": "Organization", "name": "MedTech Terms", "url": "https://medtechterms.com" }, "isPartOf": { "@type": "WebSite", "name": "MedTech Terms", "url": "https://medtechterms.com" }, "datePublished": "2026-05-05", "dateModified": "2026-05-05", "citation": [ { "@type": "CreativeWork", "name": "SVB: bridge financing", "url": "https://www.svb.com/", "publisher": { "@type": "Organization", "name": "SVB" } }, { "@type": "CreativeWork", "name": "PitchBook - MedTech Coverage", "url": "https://pitchbook.com/news/articles/topic/healthtech", "publisher": { "@type": "Organization", "name": "PitchBook" } }, { "@type": "CreativeWork", "name": "NVCA Model Documents", "url": "https://nvca.org/model-legal-documents/", "publisher": { "@type": "Organization", "name": "NVCA" } } ], "mentions": [ { "@type": "DefinedTerm", "@id": "https://medtechterms.com/terms/safe-note#term", "name": "Simple Agreement for Future Equity", "alternateName": "SAFE", "url": "https://medtechterms.com/terms/safe-note" }, { "@type": "DefinedTerm", "@id": "https://medtechterms.com/terms/convertible-note#term", "name": "Convertible Note", "url": "https://medtechterms.com/terms/convertible-note" }, { "@type": "DefinedTerm", "@id": "https://medtechterms.com/terms/runway#term", "name": "Runway", "url": "https://medtechterms.com/terms/runway" } ] }, { "@type": "BreadcrumbList", "itemListElement": [ { "@type": "ListItem", "position": 1, "name": "Home", "item": "https://medtechterms.com/" }, { "@type": "ListItem", "position": 2, "name": "Terms", "item": "https://medtechterms.com/terms" }, { "@type": "ListItem", "position": 3, "name": "Investment & Finance", "item": "https://medtechterms.com/terms?cat=Investment%20%26%20Finance" }, { "@type": "ListItem", "position": 4, "name": "Bridge Round", "item": "https://medtechterms.com/terms/bridge-round" } ] }, { "@type": "FAQPage", "@id": "https://medtechterms.com/terms/bridge-round#faq", "mainEntity": [ { "@type": "Question", "name": "How does a bridge round affect a company's regulatory strategy?", "acceptedAnswer": { "@type": "Answer", "text": "A bridge round can provide the necessary capital to continue financing regulatory-critical activities, such as clinical studies required for FDA approval or CE mark, thereby maintaining momentum in the regulatory strategy. It allows companies to address unexpected delays without sacrificing critical compliance efforts." } }, { "@type": "Question", "name": "Can a bridge round impact the timeline for regulatory submissions?", "acceptedAnswer": { "@type": "Answer", "text": "Yes, by extending financial runway, a bridge round can help a company navigate unforeseen delays in product development or clinical trials, which might otherwise stall regulatory submissions. Conversely, a poorly managed bridge round can create financial pressure that negatively impacts submission timelines." } }, { "@type": "Question", "name": "Are there any regulatory reporting implications related to bridge rounds?", "acceptedAnswer": { "@type": "Answer", "text": "While bridge rounds themselves are not typically subject to medical device regulatory reporting, the financial stability they provide contributes to a company's ability to fulfill ongoing regulatory obligations, such as adverse event reporting or quality system audits, as mandated by authorities like the FDA or notified bodies under the EU MDR." } } ] } ] } --- [ MedTech Terms The authoritative reference ](/) Browse Learn [Latest](/latest) About 1. [Home](/) 2. / 3. [Terms](/terms) 4. / 5. [Investment & Finance](/terms?cat=Investment%20%26%20Finance) 6. / 7. Bridge Round [All terms](/terms) Investment & Finance [Startup Lifecycle](/ecosystems/startup-lifecycle) # Bridge Round Interim financing between priced rounds, usually convertible. Reviewed by [Christian Espinosa, Founder, Blue Goat Cyber](/authors/christian-espinosa) Last reviewed May 5, 2026 ## Definition A bridge round is short-term financing - typically a [convertible note](/terms/convertible-note) or [SAFE](/terms/safe-note) - that extends [runway](/terms/runway) to the next priced round or a defined milestone. What the regulation says While not directly addressed by specific medical device regulations, bridge rounds indirectly impact regulatory compliance by enabling continued operations and funding for activities like clinical trials and quality system maintenance, both of which are critical for demonstrating conformity with requirements such as those in 21 CFR Part 820 ( [Quality System Regulation](/terms/qsr)) and EU [MDR](/terms/mdr-reporting) (Regulation (EU) 2017/745) Annex I ( [General Safety and Performance Requirements](/terms/gspr)). The financial stability provided by a bridge round can be crucial for a company to complete necessary regulatory submissions and [post-market surveillance](/terms/post-market-surveillance) activities. ## What this means in practice Bridges are common in MedTech to span trial enrollment delays or FDA review timelines. 'Bridge to nowhere' is the cautionary phrase: bridges without a clear next milestone often become recapitalizations. ## Examples - A startup secures a bridge round to fund an unexpected extension of its pivotal clinical trial, ensuring it can generate sufficient data for its FDA Pre-Market Approval (PMA) submission. - A MedTech company uses a bridge round to cover increased operational costs while awaiting a Notified Body’s review of its technical documentation for CE Mark under the EU MDR. - A cybersecurity firm providing solutions for medical devices obtains a bridge round to complete a critical penetration test and security audit, fulfilling a key requirement for its regulatory compliance. Common pitfalls - • Confusing a bridge round with a long-term financing solution can lead to inadequate planning for future funding needs and potential disruptions to regulatory timelines. - • Failing to clearly define the milestones a bridge round is intended to achieve can result in a "bridge to nowhere," jeopardizing the ability to fund essential regulatory activities. - • Inadequate due diligence regarding the terms and conditions of a bridge round could introduce financial constraints that impact investment in critical quality, regulatory, or cybersecurity infrastructure. - • Underestimating the time and resources required to achieve the milestones funded by a bridge round can lead to subsequent financial crises, potentially affecting product development and regulatory approval processes. - • Poor management of bridge round funds might result in insufficient capital for essential compliance activities, such as clinical data collection or post-market surveillance. ## Frequently asked questions How does a bridge round affect a company's regulatory strategy? A bridge round can provide the necessary capital to continue financing regulatory-critical activities, such as clinical studies required for FDA approval or [CE mark](/terms/ce-mark), thereby maintaining momentum in the regulatory strategy. It allows companies to address unexpected delays without sacrificing critical compliance efforts. Can a bridge round impact the timeline for regulatory submissions? Are there any regulatory reporting implications related to bridge rounds? ## Related terms Grouped by theme ### Editor's picks · Hand-selected related concepts [ Investment & Finance Convertible Note Short-term debt that converts into equity at a future financing round. ](/terms/convertible-note)[ Investment & Finance Runway Months of operating cash a company has before running out. ](/terms/runway)[ Investment & Finance Simple Agreement for Future Equity(SAFE) Convertible instrument that converts to equity at a future priced round. ](/terms/safe-note) ### More in Investment & Finance · Same category [ Investment & Finance 409A Valuation An independent fair-market-value appraisal of common stock used to set tax-compliant strike prices for employee stock options. ](/terms/409a-valuation)[ Investment & Finance Anti-Dilution Protection Adjustment that protects investors if the company raises a future round at a lower price. ](/terms/anti-dilution)[ Investment & Finance Burn Rate Rate at which a company spends cash, typically expressed monthly. ](/terms/burn-rate)[ Investment & Finance Burn Rate and Runway Monthly net cash consumption (burn) and months of cash remaining (runway). ](/terms/burn-runway) Cited by Where this term appears across MedTech Terms. Ecosystems (1) - [Startup Lifecycle](/ecosystems/startup-lifecycle) ## Primary references 3 sources Link health: 3 verified · last checked 2026-06-20 SVB· 1 PitchBook· 1 NVCA· 1 1. [1 SVB: bridge financing Verified SVB · svb.com ](https://www.svb.com/) 2. [2 PitchBook - MedTech Coverage Verified PitchBook · pitchbook.com ](https://pitchbook.com/news/articles/topic/healthtech) 3. [3 NVCA Model Documents Verified NVCA · nvca.org ](https://nvca.org/model-legal-documents/) Inline markers like \[1\] jump to the matching reference above. Sponsor note ### Diligencing a MedTech cybersecurity posture? Blue Goat Cyber supports investors and acquirers with cybersecurity diligence on connected MedTech assets. [Book a 30-minute discovery session](https://go.bluegoatcyber.com/meetings/blue-goat-cyber/discovery-session) - No obligation - Expert-led from minute one - NDA available on request MedTech Terms is a community resource sponsored by [Blue Goat Cyber](https://bluegoatcyber.com). Definitions are independent of any vendor. On this term Category Investment & Finance Sources 3 Updated 5/5/2026 [Compare with another term](/compare?a=bridge-round) Learn in 60 seconds Card Lesson Quiz Interim financing between priced rounds, usually convertible. - · Bridges are common in MedTech to span trial enrollment delays or FDA review timelines. - · 'Bridge to nowhere' is the cautionary phrase: bridges without a clear next milestone often become recapitalizations. Remember this Watch out: Confusing a bridge round with a long-term financing solution can lead to inadequate planning for future funding needs and potential disruptions to regulatory timelines. Related terms - [Simple Agreement for Future Equity(SAFE) ](/terms/safe-note) - [Convertible Note ](/terms/convertible-note) - [Runway ](/terms/runway) You may also need Auto-suggested from Investment & Finance and shared keywords. - [Valuation Cap ](/terms/valuation-cap) - [409A Valuation ](/terms/409a-valuation) - [Capitalization Table(Cap Table) ](/terms/cap-table) - [Employee Option Pool ](/terms/option-pool) - [Royalty Financing ](/terms/royalty-financing) - [Series A / B / C Financing Rounds ](/terms/series-funding) [All Investment & Finance terms](/terms?cat=Investment%20%26%20Finance) MedTech Terms An authoritative, plain-language reference for the regulatory, quality, cybersecurity, and software terms that shape modern medical devices. Browse - [All terms](/terms) - [A–Z index](/a-z) - [Categories](/categories) - [Ecosystems](/ecosystems) - [Learning paths](/paths) - [Compare terms](/compare) - [Quiz](/quiz) Resources - [FDA Medical Devices](https://www.fda.gov/medical-devices) - [EU MDR](https://eur-lex.europa.eu/eli/reg/2017/745/oj) - [IMDRF](https://www.imdrf.org/) - [Methodology](/methodology) - [Changelog](/changelog) - [Editor: Christian Espinosa](/authors/christian-espinosa) - [About this site](/about) © 2026 MedTech Terms. Reference content for educational purposes - not regulatory advice. A community resource sponsored by [Blue Goat Cyber](https://bluegoatcyber.com)